SCHEMBL8091642

SCHEMBL8091642

C=CCS(=O)(=O)NC(=O)Nc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 2/20 0.57
TP53 P04637 1/20 0.50
EPHX1 P07099 1/20 0.50
TSHR P16473 1/20 0.50
EPHX2 P34913 1/20 0.50
CDK9 P50750 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CLK4 Q9HAZ1 1/20 0.50
LMNA P02545 1/20 0.48
TGM2 P21980 1/20 0.47
CA12 O43570 3/20 0.45
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA9 Q16790 3/20 0.45
CYP2C9 P11712 1/20 0.44
CASP3 P42574 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
MAOA P21397 2/20 0.43
MAOB P27338 2/20 0.43
TAAR1 Q96RJ0 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6464378 0.84 SAE1 (0.45) ACP1TSHRSMN1; SMN2LMNACA12
SCHEMBL6468746 0.77 KDM4E (0.51) EPHX1SMN1; SMN2CA12CA1CA2
SCHEMBL6393324 0.77 LMNA (0.49) LMNACA12CA1CA9MAOA
SCHEMBL6464498 0.77 ACP1 (0.61) ACP1TP53EPHX1TSHREPHX2
SCHEMBL321565 0.75 KEAP1 (0.47) LMNATGM2CA12CA1CA2
SCHEMBL8318477 0.75 ACP1 (0.74) ACP1TP53EPHX1TSHREPHX2
SCHEMBL1649522 0.74 EPHX1 (0.59) TP53EPHX1TSHREPHX2CDK9
SCHEMBL11131714 0.73 IDO1 (0.54) TSHRSMN1; SMN2LMNATGM2CA12
Ammonia Solution, Strong SCHEMBL11319855 0.73 EPHX1 (0.57) TP53EPHX1TSHREPHX2CDK9
SCHEMBL10771388 0.72 L3MBTL1 (0.49) SMN1; SMN2TGM2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed